Swedish Growth Companies With Up To 35% Insider Ownership
In This Article:
As global markets navigate through fluctuating economic signals, Sweden's market remains a focal point for investors looking for growth opportunities. Amidst this backdrop, companies with high insider ownership can signal strong confidence in future prospects, making them particularly compelling in the current environment.
Top 10 Growth Companies With High Insider Ownership In Sweden
| Name | Insider Ownership | Earnings Growth |
| CTT Systems (OM:CTT) | 16.9% | 21.6% |
| Biovica International (OM:BIOVIC B) | 18.5% | 73.8% |
| edyoutec (NGM:EDYOU) | 14.6% | 63.1% |
| Yubico (OM:YUBICO) | 37.5% | 43.8% |
| Sileon (OM:SILEON) | 20.3% | 109.3% |
| KebNi (OM:KEBNI B) | 37.8% | 90.4% |
| InCoax Networks (OM:INCOAX) | 18.1% | 104.9% |
| BioArctic (OM:BIOA B) | 34% | 50.9% |
| Calliditas Therapeutics (OM:CALTX) | 11.6% | 52.9% |
| SaveLend Group (OM:YIELD) | 23.3% | 103.4% |
Here we highlight a subset of our preferred stocks from the screener.
AB Sagax
Simply Wall St Growth Rating: ★★★★☆☆
Overview: AB Sagax (publ) is a property company with operations across Sweden, Finland, France, Benelux, Spain, Germany, and other European countries, boasting a market capitalization of SEK 105.78 billion.
Operations: The company generates revenue primarily through real estate rentals, amounting to SEK 4.47 billion.
Insider Ownership: 28.3%
AB Sagax, a Swedish property investment company, demonstrates robust growth potential with forecasted earnings growth significantly surpassing the Swedish market average at 33.5% annually. Despite recent substantial green bond issuances totaling €500 million for corporate purposes under its Green Finance Framework, concerns linger due to shareholder dilution and debt not being well covered by operating cash flow. The company's high insider ownership aligns interests but financial leverage remains a point of caution.
Vimian Group
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Vimian Group AB operates globally in the animal health sector and has a market capitalization of approximately SEK 18.96 billion.
Operations: Vimian Group's revenue is generated through several segments, including Medtech (€109.03 million), Diagnostics (€21.14 million), Specialty Pharma (€153.26 million), and Veterinary Services (€51.63 million).
Insider Ownership: 11.1%
Vimian Group, a growth-oriented firm in Sweden, showcases promising prospects with its earnings expected to significantly outpace the Swedish market. Insider activities underscore confidence, with more buying than selling observed recently. However, challenges include a low forecasted return on equity and financial impacts from one-off items. Recent leadership changes with Magnus Welander's election as chairman could steer future strategies. Trading at 36% below estimated fair value suggests potential undervaluation relative to peers.